Session Details
[D1-A3]After the implementation of ICH-M10 guideline: Questions and concerns in the real bioanalytical field
Mon. Mar 3, 2025 4:00 PM - 5:00 PM JST
Mon. Mar 3, 2025 7:00 AM - 8:00 AM UTC
Mon. Mar 3, 2025 7:00 AM - 8:00 AM UTC
Medium Hall(2nd Floor)
Chairman:Yuki Takamatsu(Takeda Pharmaceutical Co., Ltd.), Hisanori Hara(B2S Life Sciences)
[D1-A3-01]After the Implementation of ICH-M10 Guideline: Questions and Concerns in the Real Bioanalytical Field
* (Chairpersons) Yuki Takamatsu1, *Hisanori Hara2 (1. Takeda Pharmaceutical Co., Ltd., 2. B2S Life Sciences)